TLSI Investigation Initiated: Levi & Korsinsky Investigates the Officers and Directors of TLSI (TLSI)

TriSalus Life Sciences Inc. told investors it expected $60-$62 million in 2026 revenue. The company's own GAAP figures told a different story -- and months later, that outlook was slashed to $54-$57 million. NEW YORK, May 15, 2026 /PRNewswire/ -- Investors in TriSalus Life Sciences Inc....